Basic Information
ProTom International Holding Corporation is a medical technology company focused on providing proton beam therapy for cancer patients. The company is dedicated to developing and offering advanced proton therapy equipment and technologies to improve the effectiveness and accessibility of cancer treatment. As a leader in the industry, ProTom assembles, tests, sells, and distributes the Radiance 330 proton therapy system. The Radiance 330 is an advanced proton therapy system that uses proton beams to precisely treat patients with cancer. The system has received U.S. FDA 510(k) clearance for commercial distribution, demonstrating its compliance with stringent medical device standards. ProTom's mission is to transform cancer treatment by expanding the accessibility of proton therapy and continuously advancing proton tomography imaging technology.
ProTom International Holding Corporation
Texas,United States of America
15~50 people
January 01, 2008
info@protominternational.com
